U.S. Hotel and Resort REITs Stock News

NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Does Kyivstar Group (NasdaqGS:KYIV) Trade At A Premium Or Fair Value?

Kyivstar Group stock has delivered a 30.1% return over the past year, yet its current checks point to pricing that looks broadly in line with fundamentals rather than clearly cheap or clearly expensive. The 30.1% one year gain puts recent shareholders comfortably ahead, which raises the question of how much of Kyivstar Group's progress is already reflected in the share price. Growth in digital services and new partnerships around areas such as AI and mobility can support revenue...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) After Earnings Reset And Recall News Looks Undervalued

Boston Scientific (BSX) is back in focus after its 29 July 2026 earnings release, which included updated 2026 sales guidance and fresh detail on restructuring, product pressures and a recent device recall. See our latest analysis for Boston Scientific. Boston Scientific’s recent earnings beat, updated guidance and the recall news have come against a backdrop of mixed momentum, with the 1 month share price return of 8.52% contrasting with a year to date share price decline of 50.66% and a 1...
NYSE:SSB
NYSE:SSBBanks

SouthState Bank (SSB) Stock Looks Cheap With Strong Returns And Modest Earnings Price

SouthState Bank has delivered a 64.0% total return over the past 5 years, yet its current share price of US$105.09 still screens as cheap against an intrinsic value estimate from the Excess Returns model and traditional market multiples. With several valuation checks pointing in the same direction, investors are weighing whether the current discount reflects mispricing or a fair assessment of the bank’s risks. Over the last 5 years SouthState Bank has returned 64.0%, which already represents...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Biologics (ABCL) Signs Vertex Deal, Is The Stock Still Cheap?

AbCellera Biologics (NasdaqGS:ABCL) shares are in focus after the company announced a new collaboration with Vertex Pharmaceuticals to discover, develop, manufacture, and commercialize multispecific T cell engagers for autoimmune diseases. See our latest analysis for AbCellera Biologics. The Vertex deal lands at a time when AbCellera Biologics has shown mixed momentum, with a 7.53% 7 day share price return, a 28.89% 90 day share price return, and a 34.67% 1 year total shareholder return,...
NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX (SNX) Could Be 23% Undervalued On Canada Leadership Change

Why the new Canada leadership move matters for TD SYNNEX stock TD SYNNEX (SNX) is back on investor radar after the company appointed Chris Fabes as President of Canada, following the retirement of long time executive Mitchell Martin earlier this year. The move puts Fabes in charge of distribution strategy, vendor relationships and customer growth across the Canadian market. This gives investors a fresh lens on how the company might pursue regional execution within its broader global IT...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta (META) Unveils Personal AI Agents And A New Instagram Vision

Mark Zuckerberg has outlined Meta Platforms' long-term plan to roll out personal AI agents across its apps, including Facebook, Instagram, and WhatsApp. The company has already launched AI agents for businesses, which Meta reports are in use by over 1 million businesses. Meta is also working on an "infinite" Instagram experience, with AI generated posts tailored to individual users. The push centers on making advanced AI tools widely accessible to both consumers and companies, not just large...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Should Upbeat Earnings Revisions Around AI and Electrification Require Action From Analog Devices (ADI) Investors?

Recently, Analog Devices attracted increased investor attention after analysts raised their earnings estimates and Zacks assigned the company a Rank #2 (Buy), signaling stronger profit expectations across its core markets. This shift in forecasts highlights how changing views on Analog Devices’ earnings power in automation, AI, and electrification can reshape its broader investment appeal. Now we’ll examine how these upward earnings estimate revisions may influence Analog Devices’ existing...
NYSE:FLUT
NYSE:FLUTHospitality

Flutter Entertainment (FLUT) Stock Still Looks Cheap On Its 65% Slump

Flutter Entertainment stock is down 65.1% over the past year. Yet the broader valuation checks still lean toward the shares looking cheap rather than fully priced. With sentiment starting to shift after recent research pointing to easing concerns around prediction markets, the gap between weak past returns and a supportive valuation read is back in focus for investors. Over the last 12 months, Flutter Entertainment has declined 65.1%, which means the market has already priced in a...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal Holdings (PYPL) Beat Expectations, Is The Stock Still Undervalued?

PayPal Holdings (PYPL) has just reported second quarter 2026 results, with higher sales and lower net income compared with a year ago. The update gives investors fresh numbers to assess the stock. See our latest analysis for PayPal Holdings. PayPal Holdings’ recent earnings beat and higher full year guidance sit against a mixed price picture. A 29.82% 1 month share price return contrasts with a 14.01% decline in 1 year total shareholder return, suggesting short term momentum but a weaker...
NasdaqGS:ULCC
NasdaqGS:ULCCAirlines

Why Frontier Group (ULCC) Is Up 16.2% After Revenue Jump But Deeper Net Loss In Q2

In late July 2026, Frontier Group Holdings, Inc. reported second-quarter results showing revenue rising to US$1,279 million from US$929 million a year earlier, while net loss widened to US$90 million and loss per share increased to US$0.39. Over the first half of 2026, revenue climbed to US$2,271 million from US$1,841 million, but net loss more than tripled to US$362 million, highlighting pressure on profitability despite higher sales. We’ll now examine how Frontier’s revenue growth...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc Health (TDOC) Is Down 23.5% After Weak Q2 And Lower 2026 Guidance Has The Bull Case Changed?

In late July 2026, Teladoc Health reported second‑quarter results showing sales declining to US$606.93 million and a wider net loss of US$38.91 million, alongside lower basic loss per share from continuing operations of US$0.21. Management also issued guidance calling for continued losses in the third quarter and full year 2026, highlighting ongoing pressure from the BetterHelp mental health unit as more users move toward insurance-covered care. We’ll now examine how Teladoc’s weaker...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Elanco (ELAN) Is Up 5.9% After Credelio Quattro Outperforms Rivals in Tick Protection Study

In July 2026, Elanco Animal Health reported new study results showing its Credelio Quattro chewable tablets kill black-legged and lone star ticks faster and more consistently through Day 28 than competing products Simparica Trio and NexGard Plus, while also carrying an FDA-approved claim for Lyme disease prevention in dogs. An important angle for investors is that Credelio Quattro’s rapid tick kill and Lyme prevention claim differentiate it within a crowded pet parasiticide market,...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Group (LCID) Rallies Into Earnings, Is The Stock Cheap Or Pricey?

Lucid Group (LCID) is drawing attention after a 2.01% gain in its latest session and more than 20% share price appreciation over the past month. The move comes ahead of its August 4 earnings report. See our latest analysis for Lucid Group. Lucid Group’s recent gains sit against a weaker backdrop, with the share price down 33.81% year to date and the 1 year total shareholder return declining 69.50%. The latest momentum hints at shifting expectations around growth and risk ahead of earnings. If...
NYSE:ENS
NYSE:ENSElectrical

Should EnerSys’ (ENS) Defense-Focused Greenville Lithium Shift Prompt a Rethink by Investors?

In July 2026, EnerSys updated its plans for a Greenville, South Carolina lithium cell plant, narrowing its focus to U.S.-based production for aerospace, defense, and specialized industrial customers, backed by an approximately US$150 million revised U.S. Department of Energy grant and about US$200 million in state and local incentives toward an estimated US$500 million investment. The shift away from its Verkor technology relationship toward long-standing aerospace and defense partners...
NYSE:F
NYSE:FAuto

Is Ford Motor (F) Cheap As Earnings Beat And Army Truck Win Lift Expectations?

Ford Motor (F) is back in focus after securing its largest U.S. military contract since the Cold War to build F Series based tactical truck prototypes, alongside a second quarter earnings beat and higher full year profit outlook. See our latest analysis for Ford Motor. Ford Motor shares have been volatile around the recent earnings beat, dividend affirmation and military truck win. The stock still shows a 23.57% 3 month share price return and a 42.37% 1 year total shareholder return, which...
NYSE:BAH
NYSE:BAHProfessional Services

Booz Allen Hamilton Holding (BAH) Could Be 12% Undervalued After AI Cyber Earnings Boost

Booz Allen Hamilton Holding (BAH) has come into focus after quarterly results were well received despite a year over year revenue decline, with management pointing to disciplined execution and improved contract performance. See our latest analysis for Booz Allen Hamilton Holding. For context, Booz Allen Hamilton Holding's share price has risen 16.18% over the past month yet remains down 17.87% year to date, while the 1 year total shareholder return is down 34.73%. This suggests recent...
NYSE:PG
NYSE:PGHousehold Products

Procter & Gamble (PG) Faces A Leadership Reset, Is The Stock Cheap Enough?

Procter & Gamble (PG) has entered a transitional phase that is drawing fresh attention from investors. Softer fiscal 2027 guidance, leadership changes, and recent margin pressure are all converging to reshape the conversation around the stock. See our latest analysis for Procter & Gamble. At a share price of US$144.49, Procter & Gamble has had a modest 1.9% year to date share price return, while the 1 year total shareholder return is down 1.27%. This suggests that momentum has cooled as...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

Is C.H. Robinson Worldwide (CHRW) Undervalued As ESOP Share Filing Clouds The Picture?

C.H. Robinson Worldwide (CHRW) is back in focus after filing a US$514.22m shelf registration for 3,500,000 common shares tied to an employee stock ownership plan offering. See our latest analysis for C.H. Robinson Worldwide. The recent shelf registration lands in a volatile spell for C.H. Robinson Worldwide, with the share price down 22.76% over 30 days and 16.68% over 90 days, even as 1-year total shareholder return sits at 31.8% and 5-year total shareholder return at 82.06%. This points to...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Does Nebius’ US$1 Billion AI Cloud Deal and New Debt Shift The Bull Case For NBIS?

Nebius Group recently secured a multiyear AI cloud contract worth more than US$1 billion, activated new Nvidia-powered capacity in Finland, and arranged a US$775 million senior secured debt facility to fund its global AI infrastructure expansion. These deals, backed by long-dated commitments from large technology customers and collateralized GPU assets, highlight how Nebius is tying its growth plans directly to contracted AI compute demand rather than relying solely on equity financing. With...
NYSE:NE
NYSE:NEEnergy Services

Will Weaker Q2 Results and Lower 2026 Outlook Change Noble's (NE) Capital Returns Narrative?

Noble Corporation plc recently reported second-quarter 2026 results showing revenue of US$719.69 million and a net loss of US$36.68 million, and subsequently lowered its full-year 2026 revenue guidance to US$2.80–US$2.90 billion. Despite weaker earnings and reduced guidance, the company maintained its US$0.50 per share third-quarter dividend and has completed a US$29.82 million share repurchase program, underscoring an ongoing commitment to capital returns. We’ll now examine how Noble’s...